In short

Deferred Lifetime Annuities (DLAs) pay a lump sum now for guaranteed income starting at a defined later age (commonly 80-85) and continuing for life, protecting against the risk of outliving savings. Post-2019 DLAs get favourable Age Pension treatment — 60% of the purchase price assessed under the assets test until 84, dropping to 30% after — but nothing is typically refunded if the purchaser dies before payments begin.

For Australian retirees designing their retirement income strategy, one of the genuine structural risks that account-based pensions do not address is the late-life longevity tail — the risk of living substantially beyond the planned horizon and exhausting savings. Account-based pensions support spending indefinitely if invested well, but rely on the retiree managing balance and drawdowns to last. If life span exceeds the planned horizon, the balance may run out, and at advanced ages returning to work or substantially reducing spending is rarely realistic. Deferred Lifetime Annuities (DLAs) are a specific product designed to address this tail risk: pay a lump sum now in exchange for guaranteed income payments commencing at a defined later age (commonly 80 or 85) and continuing for life. The combination of an account-based pension for early-to-mid retirement plus a DLA for late-life income produces a more robust income picture than either alone (MoneySmart — annuities, https://moneysmart.gov.au/retirement-income/annuities, accessed 6 May 2026).

A DLA is structurally a lifetime annuity with a deferred commencement date. The purchaser pays a lump sum at retirement (or in early retirement years). Between purchase and the deferred commencement age, no payments are made. From the deferred commencement age, payments begin and continue for the rest of the purchaser's life. The structure is sometimes called "longevity insurance" or, drawing on the historical pooling concept, "tontine-style." Members who die before the deferred commencement age effectively contribute their unused premium to those who live to receive payments — and this pooling of mortality risk produces higher expected payments than would be available from products where capital is preserved for the estate.

The structural attraction for retirees is the protection of the late-life income tail. For most retirees, the financial risk of running out of money increases substantially after age 85. A retiree at 65 with $1 million and a 4% withdrawal rate has a substantial probability of supporting their spending to about age 90; the longevity tail beyond that age is the planning vulnerability. The DLA addresses this directly — guaranteed income from age 85 onward eliminates the tail risk entirely. The retiree who has both an account-based pension (covering early-to-mid retirement) and a DLA (covering late retirement) can manage their ABP drawdowns more comfortably, knowing the DLA backstop will arrive at the deferred age.

The Centrelink treatment of DLAs purchased after 1 July 2019 is one of the more notable features. Under the innovative income stream framework introduced from that date, DLAs receive specific treatment under the Age Pension means tests, set out in DSS Guide 4.9.3.35 (https://guides.dss.gov.au/social-security-guide/4/9/3/35, accessed 6 May 2026). Broadly, for the assets test, 60% of the purchase price is assessable up to age 84, reducing to 30% from age 85 onwards (a 40% assets-test discount until 84, then a further reduction). For the income test, once payments commence, 60% of the actual annual payment counts as assessable income (Services Australia — income streams, https://www.servicesaustralia.gov.au/income-streams, accessed 6 May 2026). This treatment is more favourable than holding the equivalent amount in account-based pension form (where the full balance is assessable as a financial asset and subject to deeming), particularly for retirees near the assets test cut-off. The Centrelink benefit can produce material Age Pension increases for the right retiree position.

The tax treatment for super-purchased DLAs follows the broader super pension framework. For members aged 60 and over, payments are typically tax-free (ATO — tax on super benefits, https://www.ato.gov.au/individuals-and-families/super-for-individuals-and-families/super/withdrawing-and-using-your-super/tax-on-super-benefits, accessed 6 May 2026). For non-super-purchased DLAs, specific tax treatment applies based on deductible amount calculations and other provisions. For most retirees using super monies to purchase DLAs, the tax treatment aligns with broader super pension rules — neither favouring nor disadvantaging DLAs relative to other super-funded retirement income.

DLAs are most commonly used as part of a combined retirement income structure rather than standalone. A typical combination is account-based pension plus DLA: the bulk of the retirement balance funds an ABP for early-to-mid retirement, while a portion (perhaps 10-25%) funds a DLA for late retirement. The structure produces flexibility (ABP) plus longevity insurance (DLA). A more comprehensive structure adds an immediate lifetime annuity alongside — providing a stable income floor from the start of retirement, supplemented by ABP for discretionary spending, with the DLA covering the late-life tail. The specific allocation depends on the retiree's risk tolerance, total wealth, spending requirements, and family circumstances. A typical practitioner approach might commit 10-25% of the retirement balance to longevity-focused products (immediate annuity, DLA, or both), with the remainder in flexible ABP and other structures.

Several specific issues are worth understanding for retirees considering DLAs. The first is pre-commencement mortality risk: if the purchaser dies before the deferred commencement age, typically nothing is paid back to the estate, though specific product features may vary. The purchase commits capital that may produce no return if mortality is early. For retirees prioritising legacy or with reduced life expectancy, this is a material consideration; for retirees prioritising late-life income certainty over legacy, the trade-off is acceptable. The second is the capital access schedule: post-2019 DLAs are subject to capital access schedules that limit commutation and provide some access to commuted value within defined parameters. The schedules are designed to balance Centrelink concession with consumer protection — preventing the use of DLAs as pure asset-test-avoidance tools. The third is provider counterparty risk: DLAs are issued by life insurance companies, and the purchaser is exposed to the issuer's solvency over potentially decades. The Australian regulatory framework (APRA prudential supervision of life insurers, https://www.apra.gov.au/life-insurance, accessed 6 May 2026) provides substantial protection but is not absolute. For retirees committing substantial capital to a long-deferred product, the issuer's strength matters. The fourth is inflation protection: DLAs may offer fixed or CPI-indexed payments — fixed payments are eroded by inflation over the long horizon between purchase and commencement, while CPI-indexed payments preserve purchasing power but typically have a higher purchase price for the same nominal benefit. For most retirees, CPI-indexation is worth the additional cost. The fifth is comparison with self-funded longevity protection: holding the equivalent capital in invested assets provides flexibility but bears longevity risk. The DLA is a deliberate trade-off — flexibility for guaranteed protection — and the choice depends on the retiree's specific position.

For retirees considering DLAs, several decision factors matter together. Total wealth and spending shapes the calculation: for retirees with substantial wealth relative to spending, a DLA may be unnecessary, while for thinner balances it substantially reduces longevity risk. Family structure matters because for retirees prioritising legacy, committing capital to a no-estate-value product is meaningful; for those without legacy concerns, the trade-off is more straightforward. Health and life expectancy enter directly — reduced life expectancy makes a DLA less appropriate, longer expectancy makes the value higher. The Centrelink position can be material because the reduced asset assessment can produce a meaningful Age Pension benefit, and modelling supports the decision. And the combined structure dominates: DLA in isolation is rarely the right answer, with combination with ABP and other products being typical.

What do worked strategy examples show?

These two cases show how the same DLA mechanism produces materially different decisions for different retiree positions. Illustrative only — not personal advice — using FY25-26 figures.

Case 1 — David, 67, single homeowner, $850,000 in super, just retired. David's main concern is outliving his savings — both his parents lived past 92. He is comfortably above the single-homeowner Age Pension assets-test cut-off of $722,000 (Services Australia, https://www.servicesaustralia.gov.au/assets-test-for-age-pension), so he currently receives no pension. He is considering committing $170,000 (about 20% of his super balance) at age 67 to a CPI-indexed DLA that begins paying at age 85, with the remaining $680,000 funding an account-based pension. Under the post-2019 innovative income stream rules, only 60% of the $170,000 (i.e. $102,000) counts as assessable assets until he turns 84, dropping to 30% ($51,000) from 85; meanwhile the $680,000 ABP balance remains assessable as a financial asset (DSS Guide 4.9.3.35, https://guides.dss.gov.au/social-security-guide/4/9/3/35). On these facts, the assets-test concession alone may move him from no-pension to a small part-pension by lifting his effective assessable assets below the cut-off, and — more importantly — he can drawdown the $680,000 ABP more confidently knowing guaranteed CPI-indexed income kicks in at 85 if he is still living. The trap is mortality risk before 85 if he chose a non-refunding contract: at 20% allocation it is acceptable as longevity insurance, but committing 50% would be aggressive without a return-of-capital feature. Pension-phase super payments are tax-free for members 60 and over (ATO tax-on-super-benefits guidance), so the tax treatment is neutral.

Case 2 — Margaret and Tom, both 67, homeowner couple receiving a part Age Pension, $1,050,000 combined super. They sit just below the couple-homeowner cut-off of $1,085,000 and receive a small part Age Pension. The longevity tail concerns them less than the household risk of one of them surviving the other into very late life on a single Age Pension rate of $1,200.90 per fortnight (Services Australia, https://www.servicesaustralia.gov.au/age-pension). They are considering committing $200,000 of combined super (about 19%) into two separate DLAs — $100,000 each, CPI-indexed, each deferred to age 85 — leaving $850,000 in account-based pensions. Under the assets-test discount, only $120,000 of the $200,000 DLA premium is assessable until either reaches 85 (60% of $200,000), which lifts them further inside the assets-test taper and increases their part Age Pension by roughly $36 per fortnight at $3 per $1,000 (Services Australia assets-test taper). When either turns 85, the assessable portion of their DLA drops to 30%, providing further pension benefit if applicable at that age. On these facts, the structure is generally rational because it adds genuine late-life longevity insurance for both, lifts the part Age Pension now, and preserves most of their ABP capacity for the active early-to-mid retirement years. The trap is treating the Centrelink benefit as the primary reason rather than the longevity-protection reason — anti-avoidance and capital access schedule rules are designed to limit DLAs being used purely as asset-test arbitrage.

A few common pitfalls remain worth flagging. Buying a DLA without understanding pre-commencement mortality risk. Choosing fixed payments without considering inflation over the long deferral period. Not coordinating with the broader retirement income structure. Ignoring the Centrelink benefit for those near assets test thresholds. And treating provider counterparty risk as zero — APRA supervision is strong but not absolute.

For retirees with longevity concerns or those near Age Pension assets test thresholds, DLAs deserve consideration as part of the retirement income product mix. Combined with an account-based pension and possibly an immediate annuity, the structure can substantially reduce longevity tail risk while preserving most of the flexibility that makes ABPs attractive.

Sources

Key takeaways

  • A DLA is a lifetime annuity with a deferred commencement date — the purchaser pays a lump sum, no payments are made until a defined age (commonly 80 or 85), and payments then continue for life, pooling mortality risk so those who die early effectively subsidise those who live longer.
  • For DLAs purchased after 1 July 2019, only 60% of the purchase price is assessable under the Age Pension assets test up to age 84, dropping to 30% from age 85 onwards, and only 60% of the actual annual payment counts under the income test once payments begin — more favourable than holding the equivalent amount in an account-based pension.
  • The main risk is pre-commencement mortality: if the purchaser dies before the deferred commencement age, typically nothing is paid to the estate, making DLAs less suitable for retirees prioritising legacy over late-life income certainty.
  • DLAs are usually held alongside, not instead of, an account-based pension — a common structure commits perhaps 10-25% of the retirement balance to a DLA (and/or an immediate annuity) for longevity insurance, with the remainder in a flexible ABP for early-to-mid retirement spending.
  • Post-2019 DLAs are subject to capital access schedules limiting commutation, are exposed to the issuing life insurer's solvency over potentially decades (though supervised by APRA), and offer a choice between fixed payments (eroded by inflation over a long deferral) or CPI-indexed payments (preserving purchasing power at a higher upfront cost).

Frequently asked questions

What is a Deferred Lifetime Annuity?

It's a lifetime annuity where you pay a lump sum now, receive no payments for a defined deferral period, and then receive guaranteed income for life starting at a set age, commonly 80 or 85. It's designed specifically to protect against the risk of outliving your savings in very late retirement, when account-based pensions have the greatest risk of running out.

How does a DLA affect my Age Pension assessment?

For DLAs purchased after 1 July 2019, only 60% of the purchase price counts under the assets test until you turn 84, dropping to 30% from age 85 onwards — a meaningful concession compared to an account-based pension, where the full balance is assessable. Once payments begin, only 60% of the actual annual payment counts under the income test.

What happens to my DLA if I die before payments start?

Typically, nothing is paid to your estate — this is the main trade-off of the product, since it pools mortality risk to fund higher payments for those who live to the deferred commencement age. This makes DLAs less suitable for retirees prioritising leaving an inheritance over guaranteed late-life income, though specific product features can vary.

Should a DLA replace my account-based pension entirely?

No — DLAs are generally used as a complement to an account-based pension, not a replacement. A typical structure allocates perhaps 10-25% of the retirement balance to a DLA for longevity insurance, leaving the remainder in an ABP for flexible spending during early-to-mid retirement, with the DLA acting as a backstop covering the late-life tail.

A note on advice. This article is general information only and doesn't account for your personal circumstances. Everyone's situation is different — before acting, it's worth talking it through with a licensed adviser who knows your full picture.